Updates from Alberta’s prescription monitoring program
Move to a two-part form
As mentioned in January, TPP Alberta is moving to a two-part prescription form to improve processes and save significant operational costs. The prescribing and submission requirements remain unchanged.
The new two-part forms are now in use. Please use up your existing stock of three-part forms before re-ordering.
When using the new two-part form, the pharmacy will receive only one copy of the secure prescription. We recommend prescribers fax the prescription to the patient’s pharmacy of choice. (Please refer to the Prescribing: Administration standard of practice).
Pharmacies will continue to send a copy of the TPP Alberta prescription only for compounded medications, veterinary use, office use or when it is a Yukon prescription.
Keeping the TPP Alberta program name
In moving from a three-part to a two-part form, the program will keep its recognized “TPP Alberta” name. However, program administrators will no longer use the word “triplicate” for TPP Alberta.
Foquest® (methylphenidate hydrochloride controlled release capsules)
Effective immediately, TPP Alberta is monitoring Foquest® as a type 2 drug (instead of a type 1 drug). Therefore, a secure TPP Alberta prescription form is no longer required. This change is based on input from prescribers, experts and from post-marketing data.
Contact TPPinfo@cpsa.ab.ca or call 1-800-561-3899 ext. 4939.